相关实验视频
Updated: Feb 23, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.2K
在帕金森病的适应性深度大脑刺激
Martijn G J de Neeling1, Bart J Keulen1, Mariëlle J Stam1
1Department of Neurology, and Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, Netherlands.
Lancet (London, England)
|February 21, 2026
概括
适应性深度大脑刺激 (aDBS) 为帕金森病提供实时,生物标志物引导的治疗. 与传统方法相比,这种方法有望实现更个性化和响应性更强的神经调节.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 帕金森病的治疗传统上依赖于固定深度大脑刺激 (DBS).
- 适应性DBS (aDBS) 引入了基于生理标记的刺激实时调制.
研究的目的:
- 概述帕金森病中aDBS的病理生理学理由.
- 审查比较aDBS与传统DBS的临床证据.
- 探索aDBS的临床实施和未来方向.
主要方法:
- 临床证据的审查,比较DBS和传统DBS.
- 分析用于传感器件和刺激算法的技术发展.
- 讨论生理标志物变异性,信号工件和编程协议.
主要成果:
- aDBS调节基于亚thalamicβ活动 (13-30 Hz) 和相关生理标志物的刺激幅度.
- 有证据表明DBS在运动改善,副作用减少和能源效率方面具有潜在的好处.
- 局限性包括生理标志物变异性和缺乏标准化的协议.
结论:
- aDBS代表了对帕金森病的生理标志物引导神经调节的转变.
- 实施需要新的基础设施,临床医师培训和进一步的现实研究.
- aDBS有望为更个性化和响应性更强的帕金森病治疗提供希望.
相关概念视频
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K